Search
for
Sort by
Research 91–120 of 526
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Application of Baricitinib in Dermatology
- Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Real-world evidence in alopecia areata treatment: A narrative review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Recent Advances in Drug Development for Hair Loss
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Alopecia Areata: Current Treatments and New Directions